AusMed Global Limited (AusMed) was founded in late 2017 and headquartered in Hong Kong Science and Technology Park. It is a fast-growing Australian life science company that specializes in developing novel non-invasive medical devices and solutions for home and point-of-care uses in response to the global challenges in diabetes, overweight, and obesity.

Its breakthrough non-invasive photonic sensing for monitoring diabetes has been patented in numerous countries including US, Australia and China. The novel KetoMetrics high-performance breath ketone analyzer system is a game changer in ketone measurement. It aims at providing a quick and accurate non-invasive measurement method for diabetic ketoacidosis (DKA) and ketosis (fat metabolism) management. The KetoMetrics AI management system and app for diet management promotes a healthy lifestyle and wellness.

AusMed obtained ISO13485, ISO9001 and is a FDA establishment. AusMed is a winner of the Judges’ Recognition Award of the HKABA NSW Chapter Business Awards 2021, and the Silver Medal of the 2022 Geneva International Exhibition of Inventions for its “High-Performance Fat Loss Management Solution”.